W
WAVEMAN · COMPANY
HBIO · Harvard Bioscience Inc
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

HBIO

HARVARD BIOSCIENCE INC
MEDICAL DEVICES · LABORATORY ANALYTICAL INSTRUMENTS · CIK 0001123494
CLUSTER · 4 INSIDERSACTIVIST 13DC-SUITE BUYING · 2☆ WATCH
INSIDER NET · 180D
$202.4K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
4
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
8
13F, latest reported quarter
REVENUE GROWTH
-8.1%
XBRL, annual
NET MARGIN
-65.5%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$202.4K over 180 days
more than 83% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
8 funds added or opened last quarter
below 88% of Medical Devices
REVENUE
-8.1% year over year
below 83% of Medical Devices
MARGIN
-65.5% net margin
below 77% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
1.4% of shares outstanding short · 5.3 days to cover · settled 2026-07-31
below 73% of Medical Devices
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
4 insiders independently bought a net $202.4K — no planned sales are queued against it.
BroadOak Income Fund, L.P. disclosed a 5%+ stake (15.34%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +63.7%
+63.7%12M
-22%+7%+37%+67%2025-092025-102025-122026-032026-052026-072026-09 2026-03-16 · Snider William bought $62.5K2026-03-17 · DENELSKY STEPHEN J bought $48.7K2026-03-17 · Snider William bought $41.1K2026-03-16 · Duke John D bought $25.1K2026-03-16 · Frost Mark T bought $25.0K2026-03-23 · BroadOak Income Fund, L.P. filed a 5%+ stake (15.34%)2026-03-23 · BroadOak Fund VI, L.P. filed a 5%+ stake (0.33%)2026-03-23 · BroadOak Capital Partners, LLC filed a 5%+ stake (15.57%)2026-03-23 · William Snider filed a 5%+ stake (15.97%)
INSIDER BUY13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
4 insiders reported buying shares.
The record shows a net $202.4K bought by insiders over 180 days, 8 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, HARVARD BIOSCIENCE INC insiders bought a net $202.4K of stock across 26 Form 4 purchases and sales, with 4 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
DENELSKY STEPHEN J
Director
BUY
2026-03-17
10,000.0
$48.7K
Snider William
Director
BUY
2026-03-17
8,475.0
$41.1K
Snider William
Director
BUY
2026-03-16
12,525.0
$62.5K
Duke John D
Chief Executive Officer
BUY
2026-03-16
5,000.0
$25.1K
Frost Mark T
Chief Financial Officer
BUY
2026-03-16
5,000.0
$25.0K
26 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 21 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
WEBER CAPITAL MANAGEMENT LLC /ADV
310,861.0 sh
$1.9M
Meros Investment Management, LP
182,992.0 sh
$1.1M
VANGUARD CAPITAL MANAGEMENT LLC
169,625.0 sh
$1.0M
NANO CAP NEW MILLENNIUM GROWTH FUND L P
143,082.0 sh
$880.0K
CORSAIR CAPITAL MANAGEMENT, L.P.
122,810.0 sh
$755.3K
5%+ owners
13D = intent to influence · 13G = passive
BroadOak Income Fund, L.P.
ACTIVIST 13D · 2026-03-23
15.34%
BroadOak Fund VI, L.P.
ACTIVIST 13D · 2026-03-23
0.33%
BroadOak Capital Partners, LLC
ACTIVIST 13D · 2026-03-23
15.57%
William Snider
ACTIVIST 13D · 2026-03-23
15.97%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Gabelli Global Mini Mites Fund
$19.5K POSITION · AS OF 2026-03-31
0.1%
ACUITAS US MICROCAP FUND
$42.8K POSITION · AS OF 2026-03-31
0.0%
Fidelity Extended Market Index Fund
$137.8K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$194.0K POSITION · AS OF 2026-03-31
0.0%
Blackstone Alternative Multi-Strategy Fund
$3.3K POSITION · AS OF 2026-03-31
0.0%
Fidelity Nasdaq Composite Index Fund
$18.0K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2022
$2.3M
-$3.7M
$495.3K
-61%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$86.5M$94.1M$112.2M$113.3M
GROSS PROFIT$49.9M$54.8M$66.1M$60.8M
OPERATING INCOME$-48.6M$-6.2M$1.9M$-6.9M
NET INCOME$-56.7M$-12.4M$-3.4M$-9.5M
EPS (DILUTED)-1.28-0.28-0.08-0.23
OPERATING CASH FLOW$6.7M$1.4M$14.0M$1.2M
CASH$8.6M$4.1M$4.3M$4.5M
LONG-TERM DEBT$35.9M$0$30.7M$43.0M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →